Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (1) Birchmeier, Walter Prof. Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Dechend, Ralf Priv. Doz. (1) Gösele, Claudia Dr. (4) Grossmann, Katja Dr. (1) Herse, Florian PD Dr. (1) Hübner, Norbert Prof. Dr. (39) Hummel, Oliver (10) Langanki, Reika (1) Lee, Young-Ae Prof. Dr. (10) Luft, Friedrich Prof. Dr. (1) Maatz, Henrike Dr. (1) Marenholz, Ingo Dr. (5) Mathas, Stephan Dr. (12) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Qadri, Fatimunnisa Dr. (1) Saar, Kathrin Dr. (7) Schulz-Menger, Jeanette Prof. Dr. (1) Selbach, Matthias Prof. Dr. (11) Spuler, Simone Prof. (1) Wenzel, Katrin Dr. (2) Wollert-Wulf, Brigitte (2) (-) Janz, Martin Dr. (11) (-) Lusatis, Simone (1) (-) Schlag, Peter M. Prof. Dr. (1) (-) Biologie maligner Lymphome (11) (-) Genetik und Genomik von Herz- Kreislauferkrankungen (2) Molekulare Herz- Kreislaufforschung (1) Molekulare Immunologie und Gentherapie (1) Translationale Onkologie solider Tumore (106) 1999 (1) 2000 (1) 2002 (1) 2003 (3) (-) 2004 (2) 2005 (2) (-) 2006 (4) (-) 2007 (3) 2008 (2) (-) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (2) 2015 (2) 2016 (1) 2017 (4) 2018 (1) 2020 (4) 2021 (3) 2022 (4) 2023 (6) 2024 (1) 12 Ergebnisse: Active Filter: Janz, Martin Dr.Lusatis, SimoneSchlag, Peter M. Prof. Dr.Biologie maligner LymphomeGenetik und Genomik von Herz- Kreislauferkrankungen2004200620072009 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 01. April 2007 / Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou 01. Mai 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas 01. Mai 2007 / Biol Chem Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway K. Wenzel K. Daskalow F. Herse S. Seitz U. Zacharias J.A. Schenk H. Schulz N. Huebner B. Micheel P.M. Schlag K.J. Osterziel C. Ozcelik S. Scherneck B. Jandrig 29. Oktober 2009 / Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch 01. September 2009 / Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz 07. April 2009 / Proc Natl Acad Sci U S A Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma S. Mathas S. Kreher K.J. Meaburn K. Joehrens B. Lamprecht C. Assaf W. Sterry M.E. Kadin M. Daibata S. Joos M. Hummel H. Stein M. Janz I. Anagnostopoulos E. Schrock T. Misteli B. Doerken Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
01. April 2007 / Leukemia Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells M. Janz T. Stuehmer L.T. Vassilev R.C. Bargou
01. Mai 2007 / Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
01. Mai 2007 / Biol Chem Expression of the protein phosphatase 1 inhibitor KEPI is downregulated in breast cancer cell lines and tissues and involved in the regulation of the tumor suppressor EGR1 via the MEK-ERK pathway K. Wenzel K. Daskalow F. Herse S. Seitz U. Zacharias J.A. Schenk H. Schulz N. Huebner B. Micheel P.M. Schlag K.J. Osterziel C. Ozcelik S. Scherneck B. Jandrig
29. Oktober 2009 / Blood C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells R. Pal M. Janz D.L. Galson M. Gries S. Li K. Johrens I. Anagnostopoulos B. Doerken M.Y. Mapara L. Borghesi L. Kardava G.D. Roodman C. Milcarek S. Lentzsch
01. September 2009 / Dtsch Med Wochenschr Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms [The molecular pathogenesis of classical Hodgkin lymphoma] S. Mathas B. Doerken M. Janz
07. April 2009 / Proc Natl Acad Sci U S A Gene deregulation and spatial genome reorganization near breakpoints prior to formation of translocations in anaplastic large cell lymphoma S. Mathas S. Kreher K.J. Meaburn K. Joehrens B. Lamprecht C. Assaf W. Sterry M.E. Kadin M. Daibata S. Joos M. Hummel H. Stein M. Janz I. Anagnostopoulos E. Schrock T. Misteli B. Doerken